
Waypoint Bio
Pioneering high-throughput in vivo testing to develop novel cell therapies for solid tumors and autoimmune diseases.
Employees
Enterprise value
$58—87m
Authorizing premium user...
Pioneering high-throughput in vivo testing to develop novel cell therapies for solid tumors and autoimmune diseases.